Related references
Note: Only part of the references are listed.Early versus Standard Antiretroviral Therapy for HIV-Infected Adults in Haiti.
Patrice Severe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Tuberculosis Treatment in HIV Infected Ugandans with CD4 Counts >350 Cells/mm3 Reduces Immune Activation with No Effect on HIV Load or CD4 Count
C. Scott Mahan et al.
PLOS ONE (2010)
Effect of tuberculosis on the survival of HIV-infected men in a country with low tuberculosis incidence
Hugo Lopez-Gatell et al.
AIDS (2008)
Effect of tuberculosis on the survival of women infected with human immunodeficiency virus
H. Lopez-Gatell et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
Impaired IFN-γ-secreting capacity in mycobacterial antigen-specific CD4 T cells during chronic HIV-1 infection despite long-term HAART
R Sutherland et al.
AIDS (2006)
Changes in HIV RNA viral load, CD4+ T-cell counts, and levels of immune activation markers associated with anti-tuberculosis therapy and cotrimoxazole prophylaxis among HIV-infected tuberculosis patients in Abidjan, Cote d'Ivoire
M Kalou et al.
JOURNAL OF MEDICAL VIROLOGY (2005)
Virological and immunological impact of tuberculosis on human immunodeficiency virus type 1 disease
Z Toossi
JOURNAL OF INFECTIOUS DISEASES (2003)
Persistent immune activation in HIV-1 infection is associated with progression to AIDS
MD Hazenberg et al.
AIDS (2003)
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
A Mocroft et al.
LANCET (2003)
Effects of human immunodeficiency virus infection on recurrence of tuberculosis after rifampin-based treatment: An analytical review
EL Korenromp et al.
CLINICAL INFECTIOUS DISEASES (2003)
Human immunodeficiency virus-1 RNA levels and CD4 lymphocyte counts, during treatment for active tuberculosis, in South African patients
L Morris et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy
PW Hunt et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy:: a collaborative analysis of prospective studies
M Egger et al.
LANCET (2002)
Immunophenotypic characterization of peripheral T lymphocytes in Mycobacterium tuberculosis infection and disease
DSS Rodrigues et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2002)
Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy
GL Dean et al.
AIDS (2002)
Impact of tuberculosis (TB) on HIV-1 activity in dually infected patients
Z Toossi et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2001)
Increased levels of activated subsets of CD4 T cells add to the prognostic value of low CD4 T cell counts in a cohort of HIV-infected drug users
J Carbone et al.
AIDS (2000)
T cell activation, apoptosis and cytokine dysregulation in the (co)pathogenesis of HIV and pulmonary tuberculosis (TB)
T Hertoghe et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2000)
Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection
M Plana et al.
AIDS (2000)
Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda
CC Whalen et al.
AIDS (2000)
Share Paper
